Soros Fund Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-1,781
Closed -$518K 205
2014
Q3
$518K Buy
+1,781
New +$518K ﹤0.01% 236